Your session is about to expire
← Back to Search
Telehealth Assessment for Alzheimer's Disease (VITAL-NP Trial)
VITAL-NP Trial Summary
This trial is testing whether a home-based assessment for Alzheimer's Disease is as effective as an in-person assessment.
VITAL-NP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VITAL-NP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 60 and 90 years old and being checked for early-stage Alzheimer's.My neurologist suspects I have Alzheimer's disease, either typical or atypical.I have a brain tumor or a confirmed diagnosis of a non-Alzheimer's neurological condition.
- Group 1: Face-to-face evaluation (FF), TeleNP evaluation
- Group 2: TeleNP evaluation, Face-to-face evaluation (FF)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been registered for this medical research?
"Affirmatively, the details hosted on clinicaltrials.gov indicate that this research endeavour is actively recruiting participants since its initial posting of June 27th 2022 and most recent update of September 2nd 2022. They are aiming to recruit 80 individuals from 1 site in particular."
What criteria must volunteers meet to be eligible for this research?
"This clinical study is enrolling 80 participants, aged between 60 and 90 years old who have Alzheimer's disease. In addition to these conditions, potential subjects should meet the following criteria: they must be in their sixties up until nineties with a diagnosis of either common AD or aberrant AD according to their neurologist's judgement; additionally, there needs to be evidence that patient's condition ranges from Mild cognitive impairment (MCI) all the way through mild dementia."
Does this research have any open enrollment spots for participants?
"Affirmative. According to clinicaltrials.gov, the medical study which made its debut on June 27th 2022 is currently recruiting patients. The trial requires 80 individuals from 1 location for it to be successful."
Does this clinical trial include participants over seventy years of age?
"To be deemed eligible for this trial, prospective participants must fall between the ages of 60 and 90. Additionally, there are 23 studies available to those under 18 and a total of 538 trials open to individuals over 65."
Share this study with friends
Copy Link
Messenger